ncRNA name
NORAD
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-224-3p/MTDH
Cancer name
Esophageal Squamous Cell Carcinoma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
NORAD upregulates MTDH to promote CDDP resistance and progression in ESCC by sponging miR-224-3p
Tissue resource
esophageal squamous cell carcinoma and matched paracarcinoma tissue specimens
Experiment
None
Institute
Fourth Hospital of Hebei Medical University
Country
China
Continent
Asia